• Home
• Partneringtools
• Reports

• In-licensing
• Out-licensing
• Companies

• Articles
• Events
• Outsourcing

• Consulting
• Jobs
• Forums

• About us
• Products
• Newsletter

Pharmalicensing Ltd
is a division of

News of the day

Industry news search

Recent news

To keep up to date with news from this category use our

Distribution of Ethical Drugs Bufferin 81mg Tablets & Bufferin 330mg Tablets
May 12, 2008--Lion Corporation ("Lion," head office: Tokyo; president: Sadayoshi Fujishige), Bristol-Myers K. K. ("BMKK," head office: Tokyo; president: Mark W. Wright) and Eisai Co., Ltd. ("Eisai," head office: Tokyo;...

Helicon Group Limited secures exclusive China rights for Collatamp® G, an innovative drug release surgical implant
PERTH, May 11 2008. HELICON GROUP LIMITED (ASX code: HCG) announced today that it had acquired the exclusive licensing rights from EUSA Pharma to Collatamp® G for the Chinese market.

ASX ANNOUNCEMENT SUMMARY
PERTH, May 11 2008. HELICON GROUP LIMITED (ASX code: HCG) announced today that it had acquired the exclusive licensing rights from EUSA Pharma to Collatamp® G for the Chinese market.

3M to Acquire Quest Technologies Inc.
ST. PAUL, Minn.--May 09, 2008-3M announced today that it has entered into a definitive agreement to acquire Quest Technologies Inc., a manufacturer of environmental monitoring equipment, including noise, heat stress and...

Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
OSAKA, Japan, and CAMBRIGE, Mass., USA, May 9, 2008 - Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Millennium Pharmaceuticals, Inc.("Millennium",Nasdaq:MLNM) today announced the successful completion...

Medifiq Healthcare ready for business following successful completion of Medisize Medical acquisition
Medifiq 9.5.2008 -- Medifiq Healthcare, a world-class manufacturer of medical devices and drug delivery systems has announced the successful completion of its acquisition of Medisize Medical. Following news of its...

NAPO PRESENTS AT ISPOR MEETING IN TORONTO
South San Francisco, California, 9 May, 2008 - Napo Pharmaceuticals, Inc., (LSE: NAPL and NAPU), announces that it presented a poster in collaboration with QualityMetric, Inc. describing the development of a patient...

SomaLogic and Otsuka Enter into Research Collaboration Focusing On Diagnostic Products and Target Validation
BOULDER, CO- May 9, 2008 - SomaLogic, Inc. announced today that SomaLogic and Otsuka Pharmaceutical Co., Ltd. entered into a collaboration agreement to use SomaLogic's proprietary aptamer technology to discover and...

Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
OSAKA, Japan, and CAMBRIDGE, Mass., May 9-- Takeda Pharmaceutical Company Limited, "Takeda", (TSE: 4502) and Millennium Pharmaceuticals, Inc., "Millennium" (Nasdaq: MLNM) today announced the successful completion of...

KINAXO Biotechnologies Enters Agreement with Onconova Therapeutics Inc.
Martinsried, Germany, May 9, 2008. KINAXO Biotechnologies announced today a cooperation between Oncovova Therapeutics Inc, Newtown, PA, USA (www.onconova.us) and KINAXO Biotechnologies. Onconova Therapeutics is a...

ENZO BIOCHEM ACQUIRES BIOMOL INTERNATIONAL, FURTHER EXPANDING ITS LIFE SCIENCES OPERATIONS
NEW YORK, NY, May 9, 2008 -- Enzo Biochem, Inc. (NYSE:ENZ) announced the acquisition on May 8th of substantially all of the U.S. based assets of BIOMOL International, LP, of Plymouth Meeting, PA, and all of the stock of...

deCODE biostructures Captures Structure Determination Milestones and Renews its Research Collaboration with Mitsubishi Tanabe Pharma Corporation
SEATTLE, May 9th, 2008--deCODE biostructures, Inc. today announced the delivery of certain milestones, including the de novo protein crystal structure of an undisclosed novel drug target, to Mitsubishi Tanabe Pharma...

DOR BioPharma Acquires Option for Third-Generation Anthrax Vaccine from Harvard University
Ewing, NJ - May 8, 2008 - DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or the "Company"), a late-stage biopharmaceutical company, announced today that it has entered into a one-year exclusive option with the President and...

Novel Therapeutic Agent for Allergic Disorders Discovered in Collaboration with AstraZeneca Progresses to Clinical Development Stage
May 8, 2008--Dainippon Sumitomo Pharma (Headquarter: Osaka, President: Kenjiro Miyatake) announces the commencement of clinical development of a novel therapeutic agent for allergic disorders in collaboration with...

IBM AND SIEMENS HEALTHCARE TEAM TO HELP COMMUNITY HOSPITALS REDUCE OPERATING COSTS AND ENERGY CONSUMPTION
ARMONK, N.Y. and MALVERN, Pa., May 7, 2008 At a time when concerns over spiraling healthcare costs and global environmental issues have grown dramatically, Siemens (www.siemens.com/healthcare) (NYSE: SI) and IBM (NYSE:...

Biosimilar G-CSF: Cooperation on Three Continents.
Toronto, ON (May 7, 2008) -- A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals...

Genedata and FRISYS Turn Over New Leaf in Systems Biology Collaboration
Basel, Switzerland, 2008/05/07 -- The long standing collaboration between bioinformatics provider Genedata and the University of Freiburg, supported by the initiative of excellence of the German Federal Government and...

PAR PHARMACEUTICAL ACQUIRES SPECTRUM PHARMACEUTICAL'S INTEREST IN SUMATRIPTAN INJECTION
Woodcliff Lake, NJ, May 7, 2008 -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it amended its agreement with Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI) for $20 million in cash to increase...

Pevion Biotech signs Cooperation Agreement with ISS
Bern, May 7th 2008 - The Istituto Superiore di Sanità (ISS) has signed an agreement with the Swiss biotechnology company Pevion Biotech Ltd for production and further clinical development of a vaccine against vaginal...

NorDiag acquires exclusive rights to infectious disease technology platform
7 May 2008: NorDiag ASA has signed an agreement with the Russian company Bionom regarding rights to a novel method of genetic engineering that produces purified antigens for infectious disease testing - the method will...

Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
BRIDGEWATER, N.J., May 07, 2008 -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced that its Board of Directors has authorized a plan to spin-off its novel biotechnology business from Enzon in a transaction...

ViroGates Enters Into a Long-Term Research Collaboration with Hvidovre Hospital
07 May 2008 - ViroGates A/S has entered into a long-term research collaboration with the Hvidovre Hospital's Clinical Research Centre. The agreement will continue to support the commercialization of the company's suPAR...

Trudell Innovation to Benefit U.S. Asthma Patients
London, Canada (7-May-08) - Trudell Medical International is pleased to announce the FDA approval of Alvesco® (ciclesonide) inhalation aerosol in combination with the AEROCOUNT® Dose Indicator. Alvesco, a novel inhaled...

New International Agreement Advances Scripps Research Study of Alcoholism
LA JOLLA, CA, May 7, 2008--The Scripps Research Institute in La Jolla, California, and the Institut de Génétique et Biologie Moléculaire et Cellulaire (IGBMC) in Strasbourg, France, have entered into an agreement that...

PAION ANNUAL GENERAL MEETING AND CENES ACQUISITION UPDATE
Aachen, 6 May 2008 - The biopharmaceutical company PAION AG (FSE PA8, ISIN DE000A0B65S3), today announced that during their Annual General Meeting held yesterday, the resolutions proposed by the management board and...

Recommended acquisition of CeNeS Pharmaceuticals PLC by Paion AG by way of Scheme of Arrangement
May 06, 2008-- On 10 April 2008, the board of directors of CeNeS and the management board of Paion announced that they had reached agreement on the terms of a recommended offer for the entire issued and to be issued...

AMDIPHARM INTERNATIONAL LTD COMPLETES ACQUISITION OF SHIRE'S MAXOLON, BARATOL, HORMONIN, CELEVAC AND TOPICYCLINE
6th May 2008 -- Amdipharm International has today announced the acquisition of a portfolio of products in several European territories from Shire Pharmaceuticals. The deal gives Amdipharm exclusive marketing rights for...

AMDIPHARM ACQUIRES NOVARTIS PORTFOLIO OF BRANDS
May 6th, 2008 -- Amdipharm is pleased to announce the acquisition of rights to a portfolio of 12 products in over 80 countries (Europe, Middle-East, Asia-Pacific and Africa) from Novartis.

DiaKine Therapeutics and Kinexum Metabolics to Develop Novel Combination Treatment to Type 1 Diabetes
CHARLOTTESVILLE, VA and HARPER'S FERRY, WV (May 6, 2008) DiaKine Therapeutics, Inc. and Kinexum Metabolics, Inc. today announced an agreement to jointly develop a new combination therapy, that has shown in preclinical...

Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays
ALISO VIEJO, Calif., May 6 -- Clarient, Inc. (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it...

BioTrove, Synchron Team Up for European Customer Solutions
Woburn, MA and Breda, The Netherlands, May 6, 2008 - BioTrove Inc. and Synchron Lab Automation today announced a distribution agreement for the BioTrove RapidFire(TM) Services Portfolio in Europe. Under the agreement,...

Warnex Announces Agreement with Desjardins Group
Laval, QC, May 6, 2008 - Warnex Inc. (TSX: WNX) announced today that it has signed an agreement with Desjardins Group, the largest financial cooperative in Canada, for financing and banking services. As part of the...

BioForce Nanosciences' European Distributor NanoandMore GMBH Sells Nano eNabler System to Italian Institute of Technology in Genova
AMES, IA, May 6, 2008 -- BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH), a leader in systems integration at the micro- and nano-scales to create products for the life sciences, is pleased to announce that European...

Isogenica completes acquisition of the principal assets of Karyon CTT
Cambridge, UK, May 6th 2008 -- Isogenica Ltd. today announced that it had acquired the principal assets of the Finnish biotechnology company, Karyon CTT Ltd. (KCTT) as well as securing a £2 million cash investment....

BATTELLE COLLABORATING WITH KOREAN PARTNERS TO ADVANCE ENERGY EFFICIENCY AND HEALTH AND LIFE SCIENCES INITIATIVES IN KOREA
Columbus, OH--May 06, 2008-Developing a strong pharmaceutical industry is a key issue in Korea. So much so, that Battelle-Korea, Battelle, Chuncheon City, Gangwon Province and Yuyu Inc., intend to collaborate and...

Strategic Diagnostics Inc. Enters Supply Agreement for Antibody Library for Study of Chromosome Proteins with University of North Carolina Chapel Hill
NEWARK, Del., May 6, 2008 - Strategic Diagnostics Inc. (Nasdaq: SDIX) - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and life...

Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
Coral Gables, Fla. - May 6, 2008 - Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, announced today that it has acquired ABR Invent and ABR Development,...

Scripps Florida Receives Grant to Improve and Expand Science Teaching in Palm Beach County Schools
JUPITER, FL, May 6, 2008--Scripps Florida, a division of The Scripps Research Institute, has been awarded a $110,000 grant to provide Palm Beach County middle and high school teachers with a summer program of...

UNIVERSITY OF EDINBURGH HUMAN EMBRYONIC STEM CELL PROGRAM AWARDED UK GRANT FUNDING
MENLO PARK, Calif., May 6, 2008 - Geron Corporation (Nasdaq: GERN) announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and...

NorDiag expands collaboration with EXACT Sciences for joint development of colorectal cancer screening technologies
Oslo, Norway - May 6, 2008: NorDiag ASA (OSE:NORD) announced today a new collaboration agreement with EXACT Sciences for the joint, scientific development of an automated nucleic acid sample purification system from...

Galapagos and Allergan enter drug discovery collaboration
Mechelen, Belgium; 6 May 2008 - Galapagos NV (Euronext: GLPG) announced today that Galapagos' service division, BioFocus DPI, will provide hit-finding services for multiple Allergan, Inc. targets. Total contract value...

Affitech announces achievement of significant milestone in antibody discovery collaboration
OSLO, NORWAY - May 6, 2008 Affitech AS, the human antibody therapeutics company announced today another successfully completed milestone in its long-term antibody discovery partnership with Peregrine Pharmaceuticals. At...

GWC Appoints Distributor for India
May 05, 2008-GWC Technologies announced an agreement with Biotron Healthcare (India) P. Ltd. under which Biotron Healthcare will serve as exclusive distributor for GWC's label-free array systems in India. Previously...

Dow AgroSciences, GVK Biosciences Announce Collaboration on Fungicide and Insecticide Discovery Research
Indianapolis and Hyderabad, India - May 05, 2008--Dow AgroSciences LLC and GVK Biosciences Private Limited of Hyderabad, India, announced today that they have entered into a discovery research agreement to combine both...

The Leukemia & Lymphoma Society and MannKind Corporation Announce Collaborative Research Agreement
WHITE PLAINS, N.Y. and VALENCIA, Calif., May 5, 2008 -- The Leukemia & Lymphoma Society (LLS) and MannKind Corporation, (MNKD), today jointly announced the execution of a collaborative research arrangement funded...

Evotec Completes Acquisition of Renovis
May 05, 2008 -- Hamburg, Germany and South San Francisco, CA - Evotec AG (Frankfurt Stock Exchange: EVT) today announced that the merger has been successfully completed and that Renovis, Inc. (traded formerly on NASDAQ:...

Insilicos Awarded Grant for Life Science Computing
Seattle, 5 May, 2008 - Seattle biotech company Insilicos announced today that the National Institutes of Health has awarded the firm a research grant to improve medical research data management software. Insilicos will...

Aircraft Medical announces Australasian deal with major supplier Medtel
EDINBURGH, May 2, 2008 - Aircraft Medical (the "Company"), the UK medical devices company, which specialises in hand held medical devices, is pleased to announce it has signed its first distribution agreement in the...

McKesson's RelayHealth Acquires HTP
May 02, 2008 -- ATLANTA-- McKesson Corporation (NYSE:MCK) today announced that RelayHealth, its connectivity services business, has acquired HTP Inc., a leading provider of revenue cycle management technology. HTP, a...

GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals
LONDON, May 2 -- GlaxoSmithKline plc (GSK) announced today that Fountain Acquisition Corporation, a wholly-owned subsidiary of GSK, is commencing a cash tender offer to purchase all outstanding shares of common stock of...

Important Regulatory Milestone
May 02, 2008 - The Medical House PLC ("TMH")(AIM:MLH) the drug delivery specialist, announced on 7 December 2006 that it had signed a development, licensing and supply agreement with a global pharmaceutical partner...

GlaxoSmithKline commences tender offer to acquire Sirtris Pharmaceuticals
London, UK - 2 May 2008 -- GlaxoSmithKline plc (GSK) announced today that Fountain Acquisition Corporation, a wholly-owned subsidiary of GSK, is commencing a cash tender offer to purchase all outstanding shares of...

St. Jude Medical and Microsoft Collaborate to Provide Patients and Physicians with Better Access to Health Records
ST. PAUL, Minn.--May 2, 2008--St. Jude Medical, Inc. (NYSE:STJ) today announced a partnership with the Microsoft Corp. Health Solutions Group to research the integration of data from implantable devices with...

Nufarm announces completion of Etigra acquisition
May 02, 2008 -- Nufarm announced today that it has completed the acquisition of certain assets and business from US based Etigra LLC, a privately owned supplier of crop protection products focused on the turf and...

Abt SRBI Collaborating on Groundbreaking Online Panel
May 2, 2008--Abt SRBI will be collaborating with a leading social researcher in a groundbreaking study that could introduce far-reaching changes in the ways in which survey data is collected. The project will test the...

CRITICAL THERAPEUTICS SIGNS DEFINITIVE AGREEMENT TO MERGE WITH CORNERSTONE BIOPHARMA
Lexington, Massachusetts and Cary, North Carolina May 1, 2008 - Critical Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company, today announced the signing of a definitive...

Biosimilar G-CSF: Cooperation on Three Continents.
Toronto, ON (May 1, 2008) -- A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals...

Renovis Stockholders Approve Acquisition by Evotec
Hamburg, Germany - May 01, 2008 - Evotec AG (Frankfurt Stock Exchange: EVT) today announced that the stockholders of Renovis, Inc. (NASDAQ: RNVS) approved the adoption of the merger agreement with Evotec at a special...

Idera Pharmaceuticals Achieves Preclinical Milestone Under Collaboration with Merck & Co., Inc.
CAMBRIDGE, Mass., May 01, 2008 -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that, under its collaboration agreement with Merck & Co., Inc., a preclinical milestone was achieved with one of its novel...

TorreyPines Therapeutics Licenses Intellectual Property from Johns Hopkins Related to Novel Uses of Glutamate Receptor Antagonists for Prevention, Treatment of Stroke, Heart Attacks
LA JOLLA, CA, May 1, 2008 - TorreyPines Therapeutics, Inc. (NASDAQ: TPTX) today announced that it has signed an exclusive license agreement with Johns Hopkins University (JHU) for intellectual property related to the...

Abbott, Takeda Conclude TAP Joint Venture
OSAKA, Japan, and ABBOTT PARK, Ill., May 1, 2008 - Abbott and Takeda Pharmaceutical Company Limited have concluded their TAP Pharmaceutical Products Inc. (TAP) joint venture.

Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma
LEXINGTON, Mass. and CARY, N.C., May 01, 2008-- Critical Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company, today announced the signing of a definitive merger...

Renovis Stockholders Approve Acquisition by Evotec
May 01, 2008 -- Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT) today announced that the stockholders of Renovis, Inc. (NASDAQ: RNVS) approved the adoption of the merger agreement with Evotec at a special...

QSV Biologics, Ltd. Awarded cGMP Manufacturing Contract by Pfizer Inc. (PFE)
EDMONTON, May 1, 2008 - QSV Biologics, Ltd (QSV), a North American based biologics CMO located in Edmonton, Canada, has been awarded a cGMP manufacturing contract for a recombinant protein under development by Pfizer,...

Wellcome Trust Sanger Institute and Applied Biosystems Announce Project to Advance Study of Cancer Genomics
CAMBRIDGE, U.K. and FOSTER CITY, Calif. - May 1, 2008 - Researchers from the United Kingdom and the United States are working together to investigate one of science's most challenging mysteries - the genetic...

BD Biosciences Announces Agreement with 3-D Matrix to Market BD(TM) PuraMatrix(TM) Peptide Hydrogel Products to the Research Community
Billerica, MA (May 1, 2008) - BD Biosciences - Discovery Labware announced today that it has entered into an exclusive worldwide supply agreement with 3-D Matrix, Ltd. (3DM) to distribute 3DM's PuraMatrix(TM) products...

Sepracor and Arrow Sign Global License and Development Agreement for XOPENEX(R)/Ipratropium Inhalation Solution Combination
MARLBOROUGH, Mass.--May 1, 2008--Sepracor Inc. (Nasdaq: SEPR) today announced that it has signed a global license and development agreement with Arrow International Limited (Arrow), a European company, for a XOPENEX...

Sepracor and Arrow Sign Global License and Development Agreement Covering Technology to Enhance Ciclesonide and BROVANA(R)
MARLBOROUGH, Mass.--May 1, 2008--Sepracor Inc. (Nasdaq: SEPR) today announced it has signed a technology license and development agreement with Arrow International Limited (Arrow), a European company, for know-how and...

Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
MARLBOROUGH, Mass., May 01, 2008 -- Sepracor Inc. (Nasdaq: SEPR) announced today that it has entered into an agreement to acquire Oryx Pharmaceuticals Inc., an affiliate of the Arrow Group. Oryx is a specialty...

Pediatrix Acquires Maryland Neonatal Group Practice
FORT LAUDERDALE, Fla., May 01, 2008 -- Pediatrix Medical Group, Inc., (NYSE: PDX) today announced it has completed the acquisition of Neonatology Associates, P.C., a neonatal physician group practice based in Rockville,...

Dr. Reddy's announces the completion of two acquisitions
Hyderabad, India, May 1, 2008: Dr. Reddy's Laboratories (NYSE: RDY) announced that it has completed two acquisitions: The Dow Chemical Company's Dowpharma Small Molecules Business associated with its Mirfield and...

Dow Announces Sale of its Dowpharma Small Molecules Business Associated with Mirfield and Cambridge, UK Sites
Midland, MI - May 01, 2008 -- The Dow Chemical Company (NYSE:DOW) finalised the sale today of its Dowpharma Small Molecules business associated with its United Kingdom sites in Mirfield and Cambridge to Dr. Reddy's...

Abbott, Takeda Conclude TAP Joint Venture
OSAKA, Japan, and ABBOTT PARK, Ill., May 1, 2008 - Abbott and Takeda Pharmaceutical Company Limited have concluded their TAP Pharmaceutical Products Inc. (TAP) joint venture.

Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network
ST. LOUIS, May 1, 2008 -- Stereotaxis, Inc. (Nasdaq: STXS) announced today the first ever bi-directional live case transmission and training course recently conducted via the Stereotaxis Odyssey(TM) Network. The Odyssey...

ROCKEBY PARTNERS WITH NOVARTS' CHINA SUBSIDIARY TO LAUNCH Pepp® IN CHINA
30 April 2008: Australian-listed Singapore-based healthcare group Rockeby biomed Ltd (ASX:RBY) is pleased to announce the launch of its Pepp® hangover remedy in China.

Entelos Announces Agreement with Lilly
Foster City, CA, April 30, 2008 - Entelos, Inc. (LSE:ENTL) a leading life sciences company building predictive computer models of human physiology and "virtual patients" for drug discovery and development, announced...

QIAGEN and BioHelix enter into licensing agreement
VENLO, The Netherlands and BEVERLY, Mass., April 30, 2008 -- QIAGEN and privately held BioHelix have announced today that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's...

EXIQON FORMS COLLABORATION WITH RIGSHOSPITALET
April 30, 2008 -- Exiqon today announces the start of a collaboration with Rigshospitalet on the development and verification of a molecular diagnostic test for the identification of cancer of unknown primary site.

Protox Announces Collaboration with FDA
Vancouver, British Columbia, April 30, 2008 - Protox Therapeutics Inc. (TSX:PRX) today announced that it has entered into a collaboration with the U.S. Food and Drug Administration (FDA) under the terms of a Cooperative...

Sequenom Announces Distribution Agreement with Invitrogen for South and Central America; Sells First MassARRAY System in Brazil
SAN DIEGO, Apr 30, 2008 -- Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced that it has entered into an agreement with Invitrogen Corporation (NASDAQ:IVGN) under which...

Hospira Acquires Sculptor
LAKE FOREST, Ill., April 30, 2008 -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, and St. Clair Health Corporation, today announced that Hospira has acquired Sculptor...

ORCHID CELLMARK SIGNS CONTRACTS TO PROVIDE FORENSIC SERVICES FOR U.K. POLICE FORCES UNDER NEWLY-AWARDED REGIONAL FORENSIC TENDER
Princeton, NJ, Apr. 30, 2008 - Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, today announced that it has signed contracts and started DNA testing and other forensic...

Endo Pharmaceuticals and the D.E. Shaw Group Agree to Settlement
CHADDS FORD, PA and NEW YORK, NY, April 30, 2008 -- Endo Pharmaceuticals Holdings, Inc. (NASDAQ: ENDP) and the D. E. Shaw group, a global investment management firm, today announced that they have reached an agreement...

Agilent Technologies Secures Exclusive License to Aktiv-Dry CAN-BD Spray-Drying Technology for Nucleic Acid API's
SANTA CLARA, Calif., and BOULDER, Colo., April 30, 2008 -- Agilent Technologies Inc. (NYSE: A) today announced that it has secured an exclusive license to Aktiv-Dry's CAN-BD drying technology for nucleic acid active...

Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
EMERYVILLE, Calif., April 30, 2008 -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII), today announced it has received approximately $2.0 million from Merz Pharmaceuticals GmbH (Merz) for sales by Merz and...

UMN Pharma Acquires Factory Site in Akita for the Manufacturing of Pandemic Influenza Vaccine
April 30, 2008 - UMN Pharma Inc. (headquartered in Akita, President & CEO: Shuichi Kanazashi, M.D., Ph.D.) today announced the acquisition of a 13,000 m2 pandemic influenza vaccine factory site located in the Akita New...

Dr. Reddy's Acquires BASF's Pharmaceutical Contract Manufacturing Business and related facility at Shreveport in the US
Hyderabad, India, April 30, 2008: Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has signed a definitive agreement to acquire BASF's pharmaceutical contract manufacturing business and related facility in...

Merck Serono and ZymoGenetics Initiate Atacicept Phase 2 Clinical Trial in Relapsing Multiple Sclerosis
SEATTLE, Apr 30, 2008 -- ZymoGenetics, Inc. (NASDAQ:ZGEN), today announced that its development partner Merck Serono, a division of Merck KGaA, Darmstadt, Germany, has initiated a Phase 2 clinical trial to evaluate the...

Start of clinical research of cancer immunotherapy using RetroNectin® expansion culture system at Tianjin Cancer Institute & Hospital, China
April 30, 2008 - Takara Bio Inc.(President and CEO: Ikunoshin Kato, Ph.D.) has entered into a collaboration agreement with Tianjin Cancer Institute & Hospital, Tianjin Medical University(President: Xishan Hao, M.D.) as...

invivodata and ClinPhone Announce Exclusive Global Partnership for ePRO Solutions
(Nottingham, UK and Pittsburgh, PA, USA 30 April 2008). ClinPhone, the world's largest Clinical Technology Organization (CTO) and invivodata inc., the leading provider of device-based eDiaries, announced today an...

Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
CALGARY, April 30, 2008 - Botaneco, a wholly-owned subsidiary of SemBioSys Genetics Inc., today announced that it has signed a feasibility agreement with Croda Enterprise Technology, part of Croda International Plc, an...

Lundbeck expands geographical rights for Circadin®
April 30, 2008 -- H. Lundbeck A/S and Neurim Pharmaceuticals Ltd. today announced that Lundbeck has obtained expanded exclusive rights to commercialize Circadin® in Asia, Latin America and other major markets such as...

BioGaia in strategic alliance with BERICAP
April 29, 2007 -- BioGaia has concluded a global collaborative agreement with Bericap Sarl, the French subsidiary to the German Bericap Group, which is one of the world´s largest manufacturers of caps and other package...

Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases
April 29, 2008 -- Foamix Ltd, a global leader in the development of dermatological foam medications and Galderma, a worldwide specialty pharmaceutical company focused on dermatology, today announced that they have...

BioSeek Initiates Research Collaboration with Lexicon Pharmaceuticals, Inc.
April 29, 2008 -- BioSeek, Inc., a pioneer in applying predictive human biology systems to drug discovery and development, announced today the initiation of a research collaboration with Lexicon Pharmaceuticals, Inc....

Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
April 29, 2008 - Premier Research Group plc (AIM: PRG), the international pharmaceutical services group, and Octagon Research Solutions, Inc. a leader in the electronic transformation of clinical R&D in the life...

Digipede and Barrie & Hibbert Join Forces to Grid-Enable Modeling Software
OAKLAND, Calif., and EDINBURGH, UK - April 29, 2008 - Digipede Technologies (www.digipede.net), the leading provider of distributed computing solutions for the Microsoft Windows platform, and Barrie & Hibbert...

Industry news: Pharmalicensing provides comprehensive industry coverage.

Products:	Partnering Consulting	Partnering Search	Company Profiling	Comparision	Partneringtools	Reports
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Outsourcing
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search	Add your event
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic	Post your article
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Company releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us